Blueberries Medical (CNSX:BBM) - Stock Price, News & Analysis

BBM Stock Overview

Blueberries Medical Corp. engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.

About the company

BBM fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Rewards

Risk Analysis

Shareholders have been substantially diluted in the past year

Makes less than USD$1m in revenue (CA$286K)

Does not have a meaningful market cap (CA$10M)

Blueberries Medical Corp. Competitors

Heritage Cannabis Holdings

CNSX:CANN

CA$5.1m

Appili Therapeutics

TSX:APLI

CA$4.9m

GABY

CNSX:GABY

CA$3.7m

Ayurcann Holdings

CNSX:AYUR

CA$4.9m

Price History & Performance

Summary of all time highs, changes and price drops for Blueberries Medical
Historical stock prices
Current Share Price	CA$0.015
52 Week High	CA$0.04
52 Week Low	CA$0.005
Beta	1.51
1 Month Change	-25.00%
3 Month Change	-40.00%
1 Year Change	-40.00%
3 Year Change	-88.00%
5 Year Change	-97.95%
Change since IPO	-97.00%

Recent updates

Shareholder Returns

	BBM	CA Pharmaceuticals	CA Market
7D	0%	-3.6%	0.7%
1Y	-40.0%	54.7%	5.5%

Price Volatility

Is BBM's price volatile compared to industry and market?
BBM volatility
BBM Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	13.8%
Market Average Movement	9.1%
10% most volatile stocks in CA Market	18.2%
10% least volatile stocks in CA Market	3.0%

Volatility Over Time: Insufficient data to determine BBM's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Facundo Garreton	blueberriesmed.com

Blueberries Medical Corp. engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia. It produces psychoactive and non-psychoactive cannabis by-products. Blueberries Medical Corp. is based in Vancouver, Canada.

Blueberries Medical Corp. Fundamentals Summary

How do Blueberries Medical's earnings and revenue compare to its market cap?
BBM fundamental statistics
Market cap	CA$9.98m
Earnings (TTM)	-CA$1.25m
Revenue (TTM)	CA$285.66k

21.0x

P/S Ratio

-4.8x

P/E Ratio

Is BBM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BBM income statement (TTM)
Revenue	CA$285.66k
Cost of Revenue	CA$175.90k
Gross Profit	CA$109.77k
Other Expenses	CA$1.36m
Earnings	-CA$1.25m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0031
Gross Margin	38.43%
Net Profit Margin	-437.76%
Debt/Equity Ratio	284.4%

How did BBM perform over the long term?

See historical performance and comparison

BBM Stock Overview

Rewards

Risk Analysis

Blueberries Medical Corp. Competitors

CNSX:CANN

CA$5.1m

TSX:APLI

CA$4.9m

CNSX:GABY

CA$3.7m

CNSX:AYUR

CA$4.9m

Price History & Performance

Recent News & Updates

Third quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.002 loss in 3Q 2022)

Second quarter 2023 earnings released: CA$0.002 loss per share (vs CA$0.003 loss in 2Q 2022)

Blueberries Medical Corp., Annual General Meeting, Oct 06, 2023

First quarter 2023 earnings released: CA$0.002 loss per share (vs CA$0.004 loss in 1Q 2022)

Full year 2022 earnings released: CA$0.009 loss per share (vs CA$0.035 loss in FY 2021)

Third quarter 2022 earnings released: CA$0.002 loss per share (vs CA$0.003 loss in 3Q 2021)

Recent updates

Third quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.002 loss in 3Q 2022)

Second quarter 2023 earnings released: CA$0.002 loss per share (vs CA$0.003 loss in 2Q 2022)

Blueberries Medical Corp., Annual General Meeting, Oct 06, 2023

First quarter 2023 earnings released: CA$0.002 loss per share (vs CA$0.004 loss in 1Q 2022)

Full year 2022 earnings released: CA$0.009 loss per share (vs CA$0.035 loss in FY 2021)

Third quarter 2022 earnings released: CA$0.002 loss per share (vs CA$0.003 loss in 3Q 2021)

Blueberries Medical Corp. announced that it has received CAD 1.47147 million in funding from Terraflos Inc.

Second quarter 2022 earnings released: CA$0.003 loss per share (vs CA$0.002 loss in 2Q 2021)

Blueberries Medical Corp., Annual General Meeting, Oct 07, 2022

High number of new directors

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

High number of new and inexperienced directors

High number of new and inexperienced directors

Less than half of directors are independent

Blueberries Medical Corp. announced that it has received CAD 1.901382 million in funding from Terraflos Inc.

Chief Financial Officer Ian Atacan has left the company

Blueberries Medical Corp. Appoints José María Forero as President of Latin American Operations, Effective February 16, 2021

New 90-day high: CA$0.23

Blueberries Medical Corp. Announces Management Changes

Blueberries Medical Corp. Receives Approval from the Colombian Agricultural Institute for the Registration of Nine Psychoactive Tetrahydrocannabinol Dominant Strains

Blueberries Medical Corp. announced that it has received CAD 1 million in funding

Shareholder Returns

Price Volatility

About the Company

Blueberries Medical Corp. Fundamentals Summary

21.0x

-4.8x

Earnings & Revenue